A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance

被引:57
作者
de Gruijl, TD
Sombroek, CC
Lougheed, SM
Oosterhoff, D
Buter, J
van den Eertwegh, AJM
Scheper, RJ
Pinedo, HM
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Div Immunotherapy, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.4049/jimmunol.176.12.7232
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Migration of dendritic cells (DC) to secondary lymphoid organs under proinflammatory conditions coincides with their maturation and acquisition of T cell stimulatory abilities. In contrast, impaired activation of DC, e.g., in tumor-conditioned environments, may hamper their activation and possibly their subsequent migration to lymph nodes, leading to either immunological tolerance or ignorance, respectively. In this study, the influence of cytokines in the peripheral skin microenvironment on the activation state of migrating cutaneous DC was assessed using an ex vivo human skin explant model. We observed a phenotypic shift from mature CD83(+) DC to immature CD14(+) macrophage-like cells within 7 days subsequent to migration from unconditioned skin. These macrophage-like cells displayed a poor T cell stimulatory ability and lacked expression of CCR7, thus precluding their migration to paracortical T cell areas in the lymph nodes. The balance of suppressive and stimulatory cytokines during the initiation of migration decided the postmigrational fate of DC with IL-10 accelerating and GM-CSF and IL-4 preventing the phenotypic switch, which proved irreversible once established. These observations indicate that, in immunosuppressed environments, a postmigrational DC-to-macrophage shift may hinder T cell activation, but also that it may be prevented by prior conditioning of the tissue microenvironment by GM-CSF and/or IL-4.
引用
收藏
页码:7232 / 7242
页数:11
相关论文
共 44 条
  • [1] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [2] BarrattBoyes SM, 1997, J IMMUNOL, V158, P4543
  • [3] Processing and presentation of antigens by dendritic cells: implications for vaccines
    Bhardwaj, N
    [J]. TRENDS IN MOLECULAR MEDICINE, 2001, 7 (09) : 388 - 394
  • [4] Characterization of human skin-derived CD1a-positive lymph cells
    Brand, CU
    Hunger, RE
    Yawalkar, N
    Gerber, HA
    Schaffner, T
    Braathen, LR
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (2-3) : 65 - 72
  • [5] Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors
    de Gruijl, TD
    Luykx-de Bakker, SA
    Tillman, BW
    van den Eertwegh, AJM
    Buter, J
    Lougheed, SM
    van der Bij, GJ
    Safer, AM
    Haisma, HJ
    Curiel, DT
    Scheper, RJ
    Pinedo, HM
    Gerritsen, WR
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (09) : 5322 - 5331
  • [6] IL-10 induces CCR6 expression during Langerhans cell development while IL-4 and IFN-γ suppress it
    Dieu-Nosjean, MC
    Massacrier, C
    Vanbervliet, B
    Fridman, WH
    Caux, C
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (10) : 5594 - 5602
  • [7] BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
    Dzionek, A
    Fuchs, A
    Schmidt, P
    Cremer, S
    Zysk, M
    Miltenyi, S
    Buck, DW
    Schmitz, J
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (11) : 6037 - 6046
  • [8] Plasmacytoid dendritic cells:: From specific surface markers to specific cellular functions
    Dzionek, A
    Inagaki, Y
    Okawa, K
    Nagafune, J
    Röck, J
    Sohma, Y
    Winkels, G
    Zysk, M
    Yamaguchi, Y
    Schmitz, J
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (12) : 1133 - 1148
  • [9] Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.3.CO
  • [10] 2-B